Displaying 251 - 260 of 530
Only topics nominated by AACE members in good standing will be considered.
Topics are reviewed by the Clinical Practice Guidelines (CPG) Oversight Committee twice a year (approximately in March and September). Approval does not guarantee that a guidance document on the topic will be developed within a certain timeframe. AACE plans initiation of approved topics in the context of current and other approved documents in queue for development, dependent on budget and availability of personnel and resources.
AACE members who nominated approved topics may apply to be considered for selection…
more
2020 Comprehensive Type 2 Diabetes Mellitus Algorithm
2019 Comprehensive Type 2 Diabetes Mellitus Algorithm
2018 Comprehensive Type 2 Diabetes Mellitus Algorithm
2018 Position Statement on Dysglycemia-Based Chronic Disease
2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes Mellitus
2017 Clinical Practice Guideline for the Management of Dyslipidemia and Prevention of Cardiovascular Disease
2017 Comprehensive Type 2 Diabetes Mellitus Algorithm
2017 Position Statement on Menopause
2017…
more
Chair and Author Qualifications to Serve on a Guidance Document Task Force
To be considered to serve as a Chair/Co-Chair/Vice Chair or an author of an AACE guideline or consensus statement for a particular task force, AACE members must complete an application and a disclosure form, submit their curriculum vitae, and meet the following qualifications:
Required qualifications
- Current AACE member in good standing
- Active in practice within last 5 years
- Publications:
- Chairs: Two (first or senior author) publications on the…
more
Answers to the most frequently asked questions.
What is an AACE clinical practice guideline?
AACE clinical practice guidelines aim to provide trustworthy, evidence-based recommendations regarding clinical practice to improve the care of patients with endocrine diseases and disorders. Recommendations in AACE guidelines are informed by systematic reviews and unbiased assessment of evidence, benefits, and harms.…
more
Obesity is a key focus area for AACE as shown by several recent AACE statements outlining a chronic care model and new terminology (adiposity-based chronic disease) for obesity to more accurately reflect obesity as a chronic disease. This new consensus statement summarizes important areas of agreement around the topics of obesity stigma and weight bias from the perspectives of the individual, clinicians, and the health care system following the May 2022 AACE Consensus Conference on improving obesity outcomes.…
more
AACE Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm provides concise visual guidance in the form of algorithms to assist with clinical decision-making for the management of persons with type 2 diabetes mellitus and related comorbidities and complications. It incorporates newer therapies and management approaches that build on previous versions of the algorithm but also aligns with the 2022 update of the AACE evidence-based clinical practice guideline “Developing a Diabetes Mellitus Comprehensive Care Plan.”…
more
AACE strives to deliver trustworthy, unbiased, and up-to-date information that ensures clinician and patient confidence in AACE content. AACE reviewed its guidance document development processes against the National Academy of Medicine Standards for Trustworthy Guidelines and the Council of Medical Specialty Societies Principles for Development of Specialty Society Clinical Guidelines to determine areas for improvement. The 2023 updated protocol for development of clinical guidance documents summarizes changes to AACE’s methodology, processes, and policies. Highlighted changes include…
more
This is Your Shot: Be a Vaccine Champion to your Patients with Diabetes!
AACE supports the recommendations of the CDC Advisory Committee on Immunization Practices (ACIP) that all persons with diabetes mellitus receive age-appropriate vaccinations according to the
CDC/ACIP schedule. AACE also recommends endocrinologists learn about and implement the
CDC’s Standards for Adult Immunization Practice, which…
more
th, td {
padding:15px;
}
AACE supports the recommendations of the CDC Advisory Committee on Immunization Practices (ACIP) that all persons with diabetes mellitus receive age-appropriate vaccinations according to the CDC/ACIP schedule. An important section of the 2022 AACE Diabetes Guideline is
Question 28: Which vaccinations should be given to persons with diabetes mellitus? Within that section are 11 recommendations and the evidence base for each on the types of vaccines adults with diabetes should receive.
Table 21 of the guideline (as shown below) provides a concise list…
more